GERM-LINE EXCLUSION OF A SINGLE P53 ALLELE BY PREMATURE TERMINATION OF TRANSLATION IN A LI-FRAUMENI SYNDROME FAMILY

被引:0
|
作者
STOLZENBERG, MC
BRUGIERES, L
GARDES, M
DESSARPSFREICHEY, F
CHOMPRET, A
BRESSAC, B
LENOIR, G
BONAITIPELLIE, C
LEMERLE, J
FEUNTEUN, J
机构
[1] INST GUSTAVE ROUSSY,ONCOL MOLEC LAB,CNRS,URA 1158,F-94805 VILLEJUIF,FRANCE
[2] INST GUSTAVE ROUSSY,DEPT PEDIAT ONCOL,F-94805 VILLEJUIF,FRANCE
[3] INSERM,U155,UNITE RECH EPIDEMIOL GENET,F-75016 PARIS,FRANCE
[4] INST GUSTAVE ROUSSY,UNITE DIAGNOST MOLEC,F-94805 VILLEJUIF,FRANCE
[5] INT AGCY RES CANC,F-69372 LYON 08,FRANCE
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Germline p53 mutations have been detected in approximately half of the families affected by the Li-Fraumeni syndrome (LFS), in which they are believed to represent the genetic status predisposing to multiple cancers. Failure to detect mutations in the other half of LFS families suggests that sequence analysis, which has been limited to the p53 gene coding region, have overlooked other genetic events lying outside of this region or/and that alterations in other gene(s) than p53 may also lead to the syndrome. In this report, we present the evidence that a single base pair deletion in the p53 coding sequence, leading to premature signal termination of translation, generates a null allele by preventing transport of mutant allele mRNAs into the cytoplasm. This allelic exclusion which confers a status of unizygote vis-a-vis the wild-type p53 gene to individuals who carry the mutant allele, leads to predisposition to multiple cancers in a Li-Fraumeni family. Thus, the loss of the wild-type p53 allele appears as the rate limiting step in tumor induction.
引用
收藏
页码:2799 / 2804
页数:6
相关论文
共 50 条
  • [1] GERM-LINE P53 MUTATIONS IN 15 FAMILIES WITH LI-FRAUMENI SYNDROME
    FREBOURG, T
    BARBIER, N
    YAN, YX
    GARBER, JE
    DREYFUS, M
    FRAUMENI, J
    LI, FP
    FRIEND, SH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 56 (03) : 608 - 615
  • [2] GERM-LINE TRANSMISSION OF A MUTATED P53 GENE IN A CANCER-PRONE FAMILY WITH LI-FRAUMENI SYNDROME
    SRIVASTAVA, S
    ZOU, ZQ
    PIROLLO, K
    BLATTNER, W
    CHANG, EH
    NATURE, 1990, 348 (6303) : 747 - 749
  • [3] A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family
    Barel, D
    Avigad, S
    Mor, C
    Fogel, M
    Cohen, IJ
    Zaizov, R
    CANCER GENETICS AND CYTOGENETICS, 1998, 103 (01) : 1 - 6
  • [4] Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome
    Wu, Chih-Chieh
    Shete, Sanjay
    Amos, Christopher I.
    Strong, Louise C.
    CANCER RESEARCH, 2006, 66 (16) : 8287 - 8292
  • [5] Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family
    Evans, SC
    Mims, B
    McMasters, KM
    Foster, CJ
    deAndrade, M
    Amos, CI
    Strong, LC
    Lozano, G
    HUMAN GENETICS, 1998, 102 (06) : 681 - 686
  • [6] Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family
    Susan C. Evans
    Betsy Mims
    Kelly M. McMasters
    Carolyn J. Foster
    Mariza deAndrade
    Christopher I. Amos
    Louise C. Strong
    Guillermina Lozano
    Human Genetics, 1998, 102 : 681 - 686
  • [7] Li-Fraumeni syndrome - A p53 family affair
    Iwakuma, T
    Lozano, G
    Flores, ER
    CELL CYCLE, 2005, 4 (07) : 865 - 867
  • [8] P53 AND THE LI-FRAUMENI SYNDROME
    MALKIN, D
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3): : 197 - 213
  • [9] P53 AND THE LI-FRAUMENI SYNDROME
    MALKIN, D
    CANCER GENETICS AND CYTOGENETICS, 1993, 66 (02) : 83 - 92
  • [10] Li-Fraumeni syndrome: Retesting archival DNA samples to identify previously unrecognized germ-line p53 mutations
    Novokmet, A.
    Baskin, B.
    Malkin, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)